LRRK2 and Parkinson disease: Research on organoids with the LRRK2 (leucine-rich repeat kinase 2) mutation—a prevalent genetic factor in both early and late-onset PD—has yielded significant insights (Kim et al., 2019; Souza et al., 2023).